Vladimir Zaharchook
Direktor/Vorstandsmitglied bei MEDISTEM INC
Profil
Vladimir Zaharchook is currently the Vice Chairman at Medistem, Inc. and Director at Nobilis Therapeutics, Inc. He has an undergraduate and graduate degree from Saint Petersburg State University of Economics.
Aktive Positionen von Vladimir Zaharchook
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDISTEM INC | Direktor/Vorstandsmitglied | - |
Nobilis Therapeutics, Inc.
 Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Direktor/Vorstandsmitglied | - |
Ausbildung von Vladimir Zaharchook
| Saint Petersburg State University of Economics | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Medistem, Inc.
 Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
Nobilis Therapeutics, Inc.
Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Commercial Services |
